azosemide has been researched along with Heart Failure in 12 studies
azosemide : A sulfonamide that is benzenesulfonamide which is substituted at positions 2, 4, and 5 by chlorine, (2-thienylmethyl)amino and 1H-tetrazol-5-yl groups, respectively. It is a diuretic that has been used in the management of oedema and hypertension.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy and safety of azosemide in patients with edema and ascites." | 9.11 | [Efficacy and safety of azosemide in patients with edema and ascites]. ( Chen, JZ; Hu, XS; Hu, YL; Huang, GZ; Huang, XS; Lin, WQ; Wu, ZG; Zhang, Y; Zheng, JC, 2005) |
| "A long-acting loop diuretic, azosemide, has been shown to improve long-term prognosis in patients with heart failure compared with a short-acting loop diuretic, furosemide." | 7.91 | Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED. ( Abe, S; Arikawa, T; Inami, S; Inoue, T; Kanaya, T; Nishikawa, R; Saito, F; Sakuma, M; Toyoda, S; Watanabe, R, 2019) |
| "We have previously reported that a long-acting loop diuretic, azosemide, reduces cardiovascular risks in patients with chronic heart failure (CHF) as compared with a short-acting one, furosemide, in Japanese Multicenter Evaluation of LOng- versus short-acting Diuretics In Congestive heart failure (J-MELODIC)." | 5.24 | Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis. ( Akasaka, T; Daimon, T; Fukui, M; Hirano, Y; Hirotani, S; Ito, H; Kawabata, M; Masuyama, T; Nakatani, S; Ohte, N; Tsujino, T; Yamamoto, K, 2017) |
| "To assess the efficacy and safety of azosemide in patients with edema and ascites." | 5.11 | [Efficacy and safety of azosemide in patients with edema and ascites]. ( Chen, JZ; Hu, XS; Hu, YL; Huang, GZ; Huang, XS; Lin, WQ; Wu, ZG; Zhang, Y; Zheng, JC, 2005) |
| "We investigated the effects of a short-acting loop diuretic (furosemide) and a long-acting loop diuretic (azosemide) on heart rate variability, fluid balance, and neurohormonal responses in patients with mild to moderate chronic congestive heart failure." | 5.09 | Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure. ( Doba, N; Imai, Y; Nakayama, T; Sakuma, Y; Shiojima, K; Tomiyama, H; Watanabe, G; Yamamoto, A; Yoshida, H, 1999) |
| "A long-acting loop diuretic, azosemide, has been shown to improve long-term prognosis in patients with heart failure compared with a short-acting loop diuretic, furosemide." | 3.91 | Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED. ( Abe, S; Arikawa, T; Inami, S; Inoue, T; Kanaya, T; Nishikawa, R; Saito, F; Sakuma, M; Toyoda, S; Watanabe, R, 2019) |
| "We compared therapeutic effects of furosemide, a short-acting loop diuretic, and azosemide, a long-acting one, in hypertensive heart failure rats to test the hypothesis that long-acting diuretics are superior to short-acting types in heart failure." | 3.73 | Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats. ( Hori, M; Mano, T; Masuyama, T; Miwa, T; Nishio, M; Ohtani, T; Sakata, Y; Yamamoto, K; Yoshida, J, 2005) |
| "We evaluated the comparative effects of furosemide, a short-acting loop diuretic, and azosemide, a long-acting loop diuretic, on neurohumoral factors and quality of life (QOL) in patients with congestive heart failure (CHF)." | 3.71 | Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure. ( Kinoshita, M; Maeda, K; Tsutamoto, T; Tsutsui, T, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitada, S | 1 |
| Kikuchi, S | 1 |
| Tsujino, T | 3 |
| Masuyama, T | 4 |
| Ohte, N | 3 |
| Toyoda, S | 1 |
| Arikawa, T | 1 |
| Inami, S | 1 |
| Nishikawa, R | 1 |
| Saito, F | 1 |
| Watanabe, R | 1 |
| Sakuma, M | 1 |
| Kanaya, T | 1 |
| Abe, S | 1 |
| Inoue, T | 1 |
| Fukui, M | 1 |
| Hirotani, S | 1 |
| Ito, H | 2 |
| Yamamoto, K | 3 |
| Akasaka, T | 2 |
| Hirano, Y | 2 |
| Daimon, T | 2 |
| Nakatani, S | 2 |
| Kawabata, M | 1 |
| Harada, K | 1 |
| Izawa, H | 1 |
| Nishizawa, T | 1 |
| Hirashiki, A | 1 |
| Murase, Y | 1 |
| Kobayashi, M | 1 |
| Isobe, S | 1 |
| Cheng, XW | 1 |
| Noda, A | 1 |
| Nagata, K | 1 |
| Yokota, M | 1 |
| Murohara, T | 1 |
| Hisatake, S | 1 |
| Nanjo, S | 1 |
| Fujimoto, S | 1 |
| Yamashina, S | 1 |
| Yuzawa, H | 1 |
| Namiki, A | 1 |
| Nakano, H | 1 |
| Yamazaki, J | 1 |
| Miyata, M | 1 |
| Sasaki, T | 1 |
| Ikeda, Y | 1 |
| Shinsato, T | 1 |
| Kubozono, T | 1 |
| Furusho, Y | 1 |
| Kusumoto, A | 1 |
| Hamasaki, S | 1 |
| Tei, C | 1 |
| Origasa, H | 1 |
| Yoshida, J | 1 |
| Mano, T | 1 |
| Sakata, Y | 1 |
| Nishio, M | 1 |
| Ohtani, T | 1 |
| Hori, M | 1 |
| Miwa, T | 1 |
| Zhang, Y | 1 |
| Hu, XS | 1 |
| Chen, JZ | 1 |
| Wu, ZG | 1 |
| Huang, GZ | 1 |
| Hu, YL | 1 |
| Huang, XS | 1 |
| Lin, WQ | 1 |
| Zheng, JC | 1 |
| Tomiyama, H | 1 |
| Nakayama, T | 1 |
| Watanabe, G | 1 |
| Shiojima, K | 1 |
| Sakuma, Y | 1 |
| Yamamoto, A | 1 |
| Imai, Y | 1 |
| Yoshida, H | 1 |
| Doba, N | 1 |
| Tsutsui, T | 1 |
| Tsutamoto, T | 1 |
| Maeda, K | 1 |
| Kinoshita, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Japanese Multicenter Evaluation of Long- Versus Short-acting Diuretics in Congestive Heart Failure[NCT00355667] | Phase 4 | 320 participants (Actual) | Interventional | 2006-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 trials available for azosemide and Heart Failure
| Article | Year |
|---|---|
The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub-analysis of the J-MELODIC study.
Topics: Aged; Biomarkers; Cardiac Catheterization; Female; Follow-Up Studies; Heart Failure; Heart Ventricle | 2018 |
Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.
Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Echocardiography; Female; Furosemide; Heart Fa | 2017 |
Beneficial effects of torasemide on systolic wall stress and sympathetic nervous activity in asymptomatic or mildly symptomatic patients with heart failure: comparison with azosemide.
Topics: Administration, Oral; Aldosterone; Cross-Over Studies; Delayed-Action Preparations; Drug Administrat | 2009 |
Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Cross-Over Studies; Female; | 2011 |
Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF).
Topics: Aged; Atrial Natriuretic Factor; Biomarkers; Chronic Disease; Delayed-Action Preparations; Echocardi | 2012 |
Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.
Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Chronic Disease; Disease-Free Survival; Female; Fu | 2012 |
[Efficacy and safety of azosemide in patients with edema and ascites].
Topics: Adolescent; Adult; Aged; Ascites; Diuretics; Double-Blind Method; Edema; Edema, Cardiac; Female; Hea | 2005 |
Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long- vs Short-Acting Diuretics in Congestive Heart Failure (J-MELODIC).
Topics: Adult; Aged; Aged, 80 and over; Delayed-Action Preparations; Diuretics; Furosemide; Heart Failure; H | 2007 |
Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure.
Topics: Blood Pressure; Cardiac Output; Chronic Disease; Cross-Over Studies; Diuretics; Echocardiography, Do | 1999 |
3 other studies available for azosemide and Heart Failure
| Article | Year |
|---|---|
Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED.
Topics: Aged; Aged, 80 and over; Disease Progression; Female; Furosemide; Glomerular Filtration Rate; Heart | 2019 |
Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats.
Topics: Animals; Echocardiography; Furosemide; Heart Failure; Interleukin-1; Norepinephrine; Rats; Rats, Inb | 2005 |
Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure.
Topics: Administration, Oral; Aged; Chi-Square Distribution; Chronic Disease; Diuretics; Dosage Forms; Femal | 2001 |